News
04-12-2011, 08:11 AM
A new discovery published online in The FASEB Journal promises to help physicians identify patients most likely to benefit from breast cancer drug therapies. If the compound, called "Nanobody," proves effective in clinical trials, it would represent a significant advance for breast cancer drug therapy because some drugs are effective only in some people...
More... (http://www.medicalnewstoday.com/articles/222130.php)
More... (http://www.medicalnewstoday.com/articles/222130.php)